Back to Journals » OncoTargets and Therapy » Volume 12

Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives

Total article views   HTML views PDF downloads Totals
10,576 Dovepress* 8,270+ 1,283 9,553
PubMed Central* 2,306 657 2,963
Totals 10,576 1,940 12,516
*Since 13 June 2019
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 1 2 4

View citations on PubMed and Google Scholar